2,301 research outputs found
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?:Pro: Provide pre-emptive treatment to asymptomatic carriers
The year in cardiovascular medicine 2022:the top 10 papers in heart failure and cardiomyopathies
[Figure: see text
Troponins and natriuretic peptides to detect cardiotoxicity:useful biomarkers or paradise lost?
Being in Two Minds-The Challenge of Heart Failure with Preserved Ejection Fraction Diagnosis with a Single Biomarker
Reverse Cardio-Oncology:Cancer Development in Patients With Cardiovascular Disease
This review focuses on reverse cardio‐oncology and highlights clinical studies, meta‐analyses, and cohorts that have evaluated cancer risk in patients with cardiovascular disease and the risk associated with treatments of cardiovascular disease. In addition, this article summarizes mechanisms of actions that mediate the cross-talk between cancer and cardiovascular disease
Diagnostic recommendations and phenotyping for heart failure with preserved ejection fraction:knowing more and understanding less?
This article refers to 'Diagnostic scores predict morbidity and mortality in patients hospitalised for heart failure with preserved ejection fraction' by F.H. Verbrugge et al., published in this issue on pages xxx
- …